Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factors impacting on drug choices. Issues for developing countries.

S A Spector1

  • 1University of California, San Diego, Department of Pediatrics, Center for Molecular Genetics and Center for AIDS Research, La Jolla, California 92093-0672, USA. saspector@ucsd.edu

Annals of the New York Academy of Sciences
|December 29, 2000
PubMed
Summary

Antiretroviral therapy for children in developing countries requires combination drug regimens and a focus on prevention. Prioritizing mother-to-infant transmission and high-risk infants is crucial for effective HIV treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected Infants.

Journal of AIDS and immune research·2017
Same author

Effect of HIV genotypic drug resistance testing on the management and clinical course of HIV-infected children and adolescents.

International journal of STD & AIDS·2013
Same author

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

HIV clinical trials·2009
Same author

Poor outcome is associated with delayed tuberculosis diagnosis in HIV-infected children in Baja California, Mexico.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2008
Same author

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.

HIV medicine·2008
Same author

Fidelity of whole-genome amplification of blood spot DNA for HLA typing and SNP analyses.

Clinical genetics·2007

Area of Science:

  • Pediatric Infectious Diseases
  • Global Health Equity
  • Antiretroviral Therapy (ART)

Background:

  • Limited resources in developing countries pose challenges for pediatric HIV care.
  • Advances in ART in developed nations offer valuable lessons for global application.
  • Monotherapy with antiretroviral agents is insufficient for children.

Purpose of the Study:

  • To outline optimal antiretroviral strategies for children in resource-limited settings.
  • To advocate for a shift towards disease prevention using antiretrovirals.
  • To call for international collaboration and pharmaceutical support for pediatric HIV treatment.

Main Methods:

  • Review of clinical data on antiretroviral therapy efficacy.
  • Analysis of factors influencing drug choices for children.

Related Experiment Videos

  • Proposal for a tiered approach to ART prioritization based on risk.

    • Main Results:

    • Combination antiretroviral therapy (three or more drugs) is essential for children.
    • Preventing mother-to-infant HIV transmission should be the highest priority.
    • Trimethoprim-sulfamethoxazole prophylaxis is recommended for infants under one year.

    Conclusions:

    • A unified, planned approach to pediatric HIV treatment is necessary.
    • International cooperation and pharmaceutical industry support are vital for equitable access to ART.
    • Patent extensions for antiretroviral drugs could incentivize support for developing countries.